Clinical Trials Directory

Trials / Unknown

UnknownNCT04004624

Physiologically Guided VT Ablation

Physiologically Guided Ablation of Reentry-Vulnerable-Zones for the Treatment of Post-Infarction Ventricular Tachycardia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Center for Cardiovascular Reseach and Innovation · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the efficacy of VT ablation guided by functional evaluation of the substrate to specifically target the reentry-vulnerable zones in patients with infarct-related VT.

Detailed description

Activation mapping of VT is the gold-standard method for description of the reentrant circuit and identification of its isthmus, however this is uncommonly accomplished due to hemodynamic non-tolerance and limited temporal and spatial resolution. Substrate mapping has been developed as an alternative method to identify the isthmus of post-infarction VT during sinus rhythm (SR). However, it has limited specificity to critical VT sites. Fundamental work in animal models of healed infarction and humans has shown that the VT isthmus corresponds to locations characterized by marked activation slowing during SR. Furthermore, these locations serve as "anchors" for multiple VT morphologies and cycle lengths. The hypothesis of this study is that activation mapping during SR or pacing can improve the specifically for identifying the critical VT sites. The aim of this prospective, multi-center controlled study is to evaluate the utility and limitations of functional mapping for guiding ablation of reentry vulnerably zones for long-term control of VT

Conditions

Interventions

TypeNameDescription
DEVICEAblationCardiac Ablation

Timeline

Start date
2014-10-12
Primary completion
2019-09-16
Completion
2020-01-01
First posted
2019-07-02
Last updated
2019-07-02

Regulatory

Source: ClinicalTrials.gov record NCT04004624. Inclusion in this directory is not an endorsement.